Cite
MLA Citation
Elias Jabbour et al.. “Phase 2 study of low‐dose clofarabine plus cytarabine for patients with higher‐risk myelodysplastic syndrome who have relapsed or are refractory to hypomethylating agents.” Cancer, vol. 123, no. 4, 2017, pp. 629–637. http://access.bl.uk/ark:/81055/vdc_100041488805.0x000053